H
Hannah K. Weir
Researcher at Centers for Disease Control and Prevention
Publications - 96
Citations - 13970
Hannah K. Weir is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 39, co-authored 91 publications receiving 10946 citations. Previous affiliations of Hannah K. Weir include University of Toronto.
Papers
More filters
Journal Article
The impact of patient follow-up on population-based survival rates.
TL;DR: Evidence is provided to support the importance of complete death ascertainment for producing accurate cancer survival statistics, and that ascertainment of deaths only should generally be sufficient for survival analysis.
Journal ArticleDOI
Trends in pediatric cancer mortality and survival in the United States
David A. Siegel,Lisa C. Richardson,S.J. Henley,Reda J. Wilson,Nicole F. Dowling,Hannah K. Weir,Eric Tai,N Buchanan Lunsford +7 more
Journal ArticleDOI
Population-Based Cancer Survival (2001 to 2009) in the United States: Findings From the CONCORD-2 Study
Hannah K. Weir,Sherri L. Stewart,Claudia Allemani,Mary C. White,Cheryll C. Thomas,Arica White,Michel P Coleman +6 more
TL;DR: This supplement to Cancer provides survival estimates by race (black vs white), state of residence at the time of diagnosis, and stage of disease at thetime of diagnosis for 9 solid tumors in men and women 1–9 and for acute lymphoblastic leukemia in children.
Journal ArticleDOI
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).
Fabio Girardi,Brian Rous,Charles A. Stiller,Gemma Gatta,Naomi Fersht,Hans H. Storm,Jessica R Rodrigues,Christian Herrmann,Rafael Marcos-Gragera,Rafael Peris-Bonet,Mikhail Valkov,Hannah K. Weir,Ryan Woods,Hui You,Patricia A Cueva,Prithwish De,Veronica Di Carlo,Tom Børge Johannesen,Carlos Anselmo Lima,Charles F. Lynch,Michel P Coleman,Claudia Allemani +21 more
TL;DR: In this article, the authors presented the histology distribution of these tumours, for patients diagnosed during 2000-2004, 2005-2009, and 2010-2014, in 60 countries on five continents and 671,085 adults.
Journal Article
Economic assessment of central cancer registry operations. Part II: developing and testing a cost assessment tool.
TL;DR: The development of a new cost data collection instrument, the National Program of Cancer Registries' Cost Assessment Tool (NPCR-CAT), which was pilot tested with a representative group of seven registries, and the lessons learned will help tailor future data collection efforts to ensure high quality data are obtained from all registries.